Skip to content

Effect of gastrointestinal infection eradication on iron stores

Effect of helicobacter pylori eradication on iron stores in patients with dyspepsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016021626593N1
Enrollment
108
Registered
2016-10-26
Start date
2016-05-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Helicobacter Pylori Infection. Condition 2: Iron Deficiency. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Iron deficiency anemia, unspecified

Interventions

Intervention 1: Intervention Group : 1- First Group : H.pylori eradication for 2 weeks and simultaneously use of iron complement for 8 weeks. 2- Second Group : H.pylori eradication for 2 weeks an
Treatment - Drugs
Intervention Group : 1- First Group : H.pylori eradication for 2 weeks and simultaneously use of iron complement for 8 weeks. 2- Second Group : H.pylori eradication for 2 weeks and when eradica
Control Group : H.Pylori eradication alone for 2 weeks. Drugs for eradication are : furazolidone 200mg/BD, omeprazole 20mg/BD, bismut 240mg/BD, Amoxicillin 1gr/BD.

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with dyspepsia symptoms who their H pylori infection was proven by endoscopy and biopsy; ferritin serum level less than 40 ng /ml; negative CRP test. Exclusion criteria: History of treatment of helicobacter pylori during last 6 months; history of iron supplement intake among last 6 months; known underlying diseases associated with iron deficiency; lack of informed consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglubin. Timepoint: Before Intervention. Method of measurement: Sysmex K21.;CRP. Timepoint: Before Intervention. Method of measurement: Latex Aglutination.;Ferritin. Timepoint: Before and After Intervention. Method of measurement: Eliza Method.

Secondary

MeasureTime frame
Ferritin. Timepoint: After Intervention. Method of measurement: Eliza Method.;Helicobacter Pylori Fecal Antigen. Timepoint: After Intervention. Method of measurement: Stool Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfarhad yarmohammadi

Zahedan University of Medical Sciences

frdflower@zaums.ac.ir+98 54 3348 6260

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026